We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Isothermal DNA Amplification Method Detects Onchocerca in Skin Biopsies

By LabMedica International staff writers
Posted on 20 Dec 2016
Print article
Image: A photomicrograph of Onchocerca volvulus microfilarial larva from a skin snip biopsy stained with Giemsa (Photo courtesy of Dr. Lee Moore).
Image: A photomicrograph of Onchocerca volvulus microfilarial larva from a skin snip biopsy stained with Giemsa (Photo courtesy of Dr. Lee Moore).
Onchocerciasis, infection with the filarial nematode Onchocerca volvulus is a neglected tropical disease, which is best known as river blindness. Diagnostic procedures for the diagnosis of infection with this nematode parasite are currently based on the microscopic detection of microfilariae in skin biopsies.

Isothermal amplification provides a simple process that rapidly and efficiently accumulates nucleic acids at constant temperature. In contrast to polymerase chain reaction (PCR)-based amplification, no temperature cycles are required, which facilitates its integration into microsystems or portable devices.

A team of scientists working with Janssen Diagnostics (Raritan, NJ, USA) collected skin biopsy samples as part of a field study in Ghana. Physical examinations were performed to identify those subjects having palpable nodules. From each participant two skin biopsies were taken, transferred individually into a single round bottom well of a 96-well plate, submerged in saline solution and after overnight incubation at room temperature each biopsy was examined microscopically and the emerged microfilariae of O. volvulus counted.

Genomic DNA was extracted from each skin biopsy using the OMEGA E.Z.N.A. tissue DNA kit (Omega Bio-tek, Norcross, GA, USA). The quantity and quality of extracted DNA was assessed with a ND-1000 NanoDrop Spectrophotometer (Thermo Scientific, Waltham, MA, USA). Loop-mediated isothermal amplification (LAMP) primers were designed targeting O. volvulus mitochondrial DNA. The detection limit of LAMP was determined to be 2 log copies/reaction as at this concentration a positive signal was reproducibly obtained in the assay.

The scientists reported that analysis of dilution series of synthetic DNA containing the targeted sequence shows a non-linear dose-response curve, as is usually the case for isothermal amplification methods. Evaluation of cross-reactivity with the heterologous sequence from the closely related parasites Wuchereria bancrofti, Loa loa and Brugia malayi demonstrated strong specificity, as none of these sequences was amplified.

Compared to a quantitative polymerase chain reaction, the LAMP assay had a sensitivity of 88.2% and a specificity of 99.2%. The authors concluded that they have developed a sensitive and specific loop-mediated amplification method for detection of O. volvulus DNA in skin biopsies that is capable of providing results within 30 minutes. The study was published on December 1, 2016, in the journal Parasites & Vectors.

Related Links:
Janssen Diagnostics
Omega Bio-tek
Thermo Fisher Scientific
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.